Tackling Underrepresentation to Aid Understanding of Parkinson’s Disease: Progress and Further Opportunities

    September 2021 in “ Physiology News
    Alastair Noyce, Dayne Beccano-Kelly, Sara Bandrés‐Ciga, Artur Francisco Schumacher Schuh, Yared Zenebe Zewde, Bernadette Siddiqi
    Image of study
    TLDR Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.
    The document emphasized the critical need to address underrepresentation in Parkinson's disease (PD) research, particularly among non-European populations, to develop more effective treatments and gain a comprehensive understanding of the disease. It highlighted initiatives like the Global Parkinson's Genetics Program (GP2) and the Latin American Research Consortium on the Genetics of PD (LARGE-PD) aimed at including diverse populations in research. The Physiological Society's commitment to equity, diversity, and inclusion (EDI) through various initiatives, including a D&I taskforce and support funds, was also discussed. The document underscored the importance of sustained investment in research and development (R&D) and the role of inclusivity in scientific progress.
    Discuss this study in the Community →